Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
HF Sinclair heads into its October 28 earnings print with analysts lifting targets at pace, an activist on the register trimming its stake, and the stock up 8% on the week to $115.63.
The analyst story is the most striking feature of the week. Coverage has been uniformly bullish in direction, with every firm that moved in the past month raising its price target rather than cutting. Mizuho's Nitin Kumar lifted his target from $85 to $119 this morning while keeping a Neutral rating. UBS raised its Buy target to $133 from $126 on Monday. Raymond James has a Strong Buy with a $140 target, and Morgan Stanley carries an Overweight at $127. Targets have moved fast: Mizuho alone raised twice since early August, from $79 to $85 and now to $119. The consensus mean of $106.47 already sits below where the stock trades, though the more bullish end of the Street, Raymond James at $140 and UBS at $133, still implies meaningful room. That gap between the consensus mean and current price is worth noting: it reflects how quickly the stock has run past some of the slower-moving targets.
The Street's bull case rests on free cash flow recovery, heavy-crude exposure and a 2026 margin rebound after a difficult patch of unplanned downtime and lubes weakness. Bears are less worried about the business model than about execution: refinery throughput still needs to recover, and leadership clarity matters for sentiment. CEO Franklin Myers took a voluntary leave of absence earlier in the year and returned to file open-market purchases in August, buying 15,000 shares at $85.30, a $1.28m bet made without a 10b5-1 plan. That purchase, now sitting on a roughly 35% gain, is a concrete data point for bulls pointing to insider confidence. Against that, an CHRO sold 8,936 shares in early August at $84.59. Net insider activity over the 90 days to September 17 was modestly positive at around 6,000 shares, a small number but directionally consistent with the CEO's conviction buy.
The activist angle adds an important overlay. REH Advisors, which has filed a Schedule 13D on DINO since September 2025, disclosed on August 4 that it had reduced its stake from 6.3% to 5.1%, delivering 2.375 million shares at $89.41 for roughly $212m. REH remains on the 13D register, meaning it has disclosed activist intent, but the stake reduction just above the 5% threshold is worth watching. As always with 13D/G positions, stakes are as-last-disclosed: a holder who drops below 5% may not file again. REH's institutional data shows it still holds around 4.99% of shares, so the position remains meaningful.
Short interest gives the overall picture more nuance. Bears have been retreating. Short interest has fallen from about 10.2 million shares in mid-September to just under 9.8 million now, roughly 5.3% of the free float. That is still a meaningful short position for a refiner, but the direction of travel over the past three weeks is unmistakably lower. Borrow remains cheap at 0.45%, and the lending pool is extremely well-supplied: availability is essentially uncapped relative to the shares borrowed, meaning new shorts face no squeeze pressure at all. The put/call ratio of 0.62 is modestly above its 20-day average of 0.56, about 1.3 standard deviations elevated, suggesting options traders have added a bit of protection into the rally but are nowhere near a panic level, the 52-week high in put/call was 1.40.
In the peer group, MPC led the week with a 11.8% gain, VLO added 9.4%, and PSX rose 6.4%. DINO's 7.7% week sits comfortably in line with the sector move, suggesting the rally is primarily macro and crack-spread driven rather than stock-specific. Valuation remains undemanding: the stock trades at a PE of 8.2x and an EV/EBITDA of 5.3x, both of which have expanded modestly over the past week as the price ran ahead of earnings estimates. The EPS momentum factor scores rank in the 91st to 94th percentile, meaning estimate revisions have been running strongly in the stock's favour.
The next focus is the October 28 print. After the last two releases, the stock fell roughly 0.9% to 1.9% on the day before recovering over the subsequent five days in one case and retreating slightly in the other. Whether that intraday caution repeats will likely depend on whether refinery throughput and the lubricants segment have recovered from the downtime that weighed on the past two quarters.
See the live data behind this article on ORTEX.
Open DINO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
